Accelero Bioanalytics GmbH Information

Welcome to Accelero® Bioanalytics GmbH Your GxP Ligand Binding Assay Partner Accelero® Bioanalytics GmbH is a biotech CRO focussing on ligand binding assays of any kind. Our expertise is the bioanalytics of INDs based on nucleic acid or protein/peptide chemistry. Accelero® Bioanalytics GmbH supports PK and PD preclinical and clinical DD on microRNA, miRNA, siRNA, aptamers, antisense, as well as peptide hormones, biosimilars, or antibody therapeutics. We are one of the first to offer GLP compliant Real-Time RT-qPCR, including human diagnostics. What you can expect: Our Services - Ligand Binding Assay GLP Lab Capabilities - GMP Cell Based Assays - Radiolabel Biodistribution - EU FP7 Grant Support - GLP Study Documentation Our experience in this field includes: - Pharmacokinetics/ Toxicokinetics - Pharmacodynamics - Mouse, rat, cynomolgus, rhesus, human - Biodistribution - Bioanalysis of virtually any biological matrix - Strong molecular biological background - >6 years aptamers in vivo - >5 years liposomal siRNA in vivo Our clients request: - Phase I bioequivalence PK studies biosimilars - Phase I PK/PD bioanalysis of a nucleic acid drug - PK of Fc fusion proteins - siRNA quant. for nanocarrier load process optimization - GMP cell-based assays enabling biologics stability testing - Immunogenicity of biosimilars according to EMA Guideline - Phase I MRSA qPCR quant. human nasal swaps Accelero® is a trademark fully owned by Accelero Bioanalytics GmbH, Berlin (Germany).